Related Experiment Video
Updated: Sep 24, 2025

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
KLF4 prevented angiotensin II-induced smooth muscle cell senescence by enhancing autophagic activity
Hongjie Xu1, Manli Yu2, Yongchao Yu1
1Department of Cardiovascular Surgery, Institute of Cardiac Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.
Background:
Vascular aging is an important risk factor for various cardiovascular diseases. Transcription factor krüppel-like factor 4 (KLF4) could regulate the phenotypic transformation of the vascular smooth muscle cell (VSMC) in the pathogenesis of aortic diseases. The present study aimed to explore the role and mechanism of KLF4 in angiotensin II (Ang II)-induced VSMC senescence.
Methods:
The VSMC senescence mouse model was induced by sustained release of Ang II (1.0 μg/kg/min) for 4 weeks. The premature senescent VSMCs were induced by Ang II (0.1 μmol/L) for 72 h. Cellular senescence was measured by senescence-associated β-galactosidase (SA-β-gal) activity and p53/p16 expression. The autophagic activity was evaluated by autophagic flux and autophagic marker expression.
Results:
The expression of KLF4 was extremely increased in abdominal aorta tissues after 1-week Ang II stimulation (p < .01) but began to decrease in later periods. Decreased expression of KLF4 was also detected in premature senescent VSMCs. Overexpression of KLF4 could enhance the antisenescence ability of VSMCs. Significantly decreased amounts of SA-β-gal-positive cells and lower p53/p16 expression were detected in KLF4-overexpressing VSMCs (p < .01). Next, telomerase reverse transcriptase (TERT) was identified as a direct downstream target of KLF4 in VSMCs. Overexpression of KLF4 in VSMCs prevented the decreased expression of TERT under Ang II stimulation condition, which could in turn, contribute to the enhanced autophagic activity, and ultimately to the improved antisenescence ability of VSMCs.
Conclusions:
Our results demonstrated that overexpression of KLF4 prevented Ang II-induced VSMC senescence by promoting TERT-mediated autophagy. These findings provided novel potential targets for the prevention and therapy of vascular aging.
Insights
Krüppel-like factor 4 (KLF4) overexpression prevents vascular smooth muscle cell (VSMC) senescence induced by angiotensin II (Ang II). This occurs by promoting telomerase reverse transcriptase (TERT)-mediated autophagy, offering potential therapeutic targets for vascular aging.
Area of Science:
- Cardiovascular Biology
- Cellular Senescence
- Molecular Mechanisms
Background:
- Vascular aging is a key risk factor for cardiovascular diseases.
- Krüppel-like factor 4 (KLF4) influences vascular smooth muscle cell (VSMC) phenotype in aortic diseases.
- The role of KLF4 in angiotensin II (Ang II)-induced VSMC senescence requires elucidation.
Purpose of the Study:
- To investigate the function and mechanism of KLF4 in Ang II-induced VSMC senescence.
- To determine if KLF4 can mitigate Ang II-mediated cellular aging in VSMCs.
Main Methods:
- Established a VSMC senescence mouse model using sustained Ang II release.
- Induced premature VSMC senescence using Ang II in vitro.
- Assessed cellular senescence via SA-β-gal activity and p53/p16 expression.
- Evaluated autophagic activity through autophagic flux and marker expression.
Main Results:
- KLF4 expression initially increased then decreased in Ang II-stimulated aortas and senescent VSMCs.
- KLF4 overexpression reduced SA-β-gal activity and p53/p16 levels, indicating reduced senescence.
- KLF4 directly targets telomerase reverse transcriptase (TERT), preventing its decrease under Ang II.
- KLF4 overexpression enhanced autophagy and antisenescence capabilities in VSMCs.
Conclusions:
- Overexpression of KLF4 inhibits Ang II-induced VSMC senescence.
- KLF4 exerts its protective effect by enhancing TERT-mediated autophagy.
- These findings highlight KLF4 as a potential therapeutic target for vascular aging.
More Related Videos
09:51Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
09:51Live Cell Imaging and 3D Analysis of Angiotensin Receptor Type 1a Trafficking in Transfected Human Embryonic Kidney Cells Using Confocal Microscopy
Published on: March 27, 2017
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...